On September 28, 2023, Yunnan Jianzhijia Chongqing Qinkang Pharmaceutical Co., Ltd. closed the transaction. The company announced that it has completed the change registration procedures, and obtained a new "Business License". The registered capital of the company is CNY 80 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51.15 CNY | +0.69% | -0.68% | -13.89% |
04-26 | Jianzhijia Pharmaceutical Chain Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-13 | JZJ Chain Drugstore Acquires 69 Pharmacies For 46 Million Yuan | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.89% | 904M | |
-28.01% | 10.96B | |
+14.69% | 6.34B | |
-10.01% | 6.08B | |
-27.59% | 6.05B | |
+72.00% | 4.98B | |
-2.48% | 4.64B | |
-6.21% | 4B | |
-17.19% | 3.28B | |
-12.21% | 2.86B |
- Stock Market
- Equities
- 605266 Stock
- News Jianzhijia Pharmaceutical Chain Group Co., Ltd.
- Yunnan Jianzhijia Chongqing Qinkang Pharmaceutical Co., Ltd. announced that it has received CNY 50 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd.